» Articles » PMID: 33505504

The Effectiveness of on Migraine: Implications from Clinical Use and Experimental Proof

Overview
Date 2021 Jan 28
PMID 33505504
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: (SB), a traditional Chinese medicine, is commonly used for the treatment of inflammatory and painful conditions. The purpose of the present study was to examine the effects of SB on migraine.

Materials And Methods: We examined the clinical applications of SB based on the data obtained from Taiwan's National Health Insurance Research Database and confirmed that it was frequently used in Taiwan for the treatment of headaches. An experimental migraine model was established in rats by an intraperitoneal injection of nitroglycerin (NTG, 10 mg/kg). Pretreatment with SB was given orally 30 min before NTG administration. The rats were subjected to migraine-related behaviour tests that were video-recorded and analysed using EthoVision XT 12.0 software.

Results: The frequency of exploratory and locomotor behaviour was comparatively lower in the NTG group than that in the control group, while the frequency of resting and grooming behaviour increased. These phenomena were ameliorated by pretreatment with 1.0 g/kg SB. The total time spent on the smooth surface was longer in the NTG group than that in the control group, but the time was shortened by pretreatment with 1.0 g/kg SB.

Conclusions: Pretreatment with 1.0 g/kg SB relieved migraine-related behaviours in the experimental NTG-induced migraine model. The outcome therefore demonstrated that pretreatment with 1.0 g/kg SB is beneficial for migraine treatment.

Citing Articles

Recent advances in : A comprehensive review on ethnobotanical uses, processing, phytochemistry, pharmacological effects, quality control and influence factors of biosynthesis.

Ma W, Liu T, Ogaji O, Li J, Du K, Chang Y Heliyon. 2024; 10(16):e36146.

PMID: 39262990 PMC: 11388511. DOI: 10.1016/j.heliyon.2024.e36146.


Efficacy and safety of the Chaixiong Qiwei granule for tension-type headache: study protocol for a randomised controlled trial.

Shen W, Fan X, Fu G, Liu H, Liang X, Wei J BMJ Open. 2023; 13(11):e074871.

PMID: 38035742 PMC: 10689380. DOI: 10.1136/bmjopen-2023-074871.


Scutellaria baicalensis georgi is a promising candidate for the treatment of autoimmune diseases.

Wang J, Chen S, Zhang J, Wu J Front Pharmacol. 2022; 13:946030.

PMID: 36188625 PMC: 9524225. DOI: 10.3389/fphar.2022.946030.

References
1.
Burch R, Buse D, Lipton R . Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019; 37(4):631-649. DOI: 10.1016/j.ncl.2019.06.001. View

2.
Sufka K, Staszko S, Johnson A, Davis M, Davis R, Smitherman T . Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats. J Headache Pain. 2016; 17:40. PMC: 4837195. DOI: 10.1186/s10194-016-0624-y. View

3.
Demartini C, Greco R, Zanaboni A, Sances G, De Icco R, Borsook D . Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back. Prog Neurobiol. 2019; 177:15-32. DOI: 10.1016/j.pneurobio.2019.02.002. View

4.
Kim K, Kang S, Lee J, Park D, Hyun J . Baicalein Attenuates Oxidative Stress-Induced Expression of Matrix Metalloproteinase-1 by Regulating the ERK/JNK/AP-1 Pathway in Human Keratinocytes. Biomol Ther (Seoul). 2013; 20(1):57-61. PMC: 3792202. DOI: 10.4062/biomolther.2012.20.1.057. View

5.
Nair A, Jacob S . A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016; 7(2):27-31. PMC: 4804402. DOI: 10.4103/0976-0105.177703. View